Drug-induced glaucomas: mechanism and management
RC Tripathi, BJ Tripathi, C Haggerty - Drug safety, 2003 - Springer
Glaucoma comprises a heterogeneous group of diseases that have in common a
characteristic optic neuropathy and visual field defects, for which elevated intraocular …
characteristic optic neuropathy and visual field defects, for which elevated intraocular …
[PDF][PDF] Side effects of glaucoma medications
M Detry-Morel - Bulletin-Societe Belge D Ophtalmologie, 2006 - researchgate.net
The safety profile of the different glaucoma medications is an important issue when initiating
therapy in glaucomatous patients. The decision on which medication to prescribe depends …
therapy in glaucomatous patients. The decision on which medication to prescribe depends …
[HTML][HTML] Non-steroidal drug-induced glaucoma
MR Razeghinejad, MJ Pro, LJ Katz - Eye, 2011 - nature.com
Numerous systemically used drugs are involved in drug-induced glaucoma. Most reported
cases of non-steroidal drug-induced glaucoma are closed-angle glaucoma (CAG). Indeed …
cases of non-steroidal drug-induced glaucoma are closed-angle glaucoma (CAG). Indeed …
Iatrogenic glaucoma secondary to medications
MR Razeghinejad, JS Myers, LJ Katz - The American journal of medicine, 2011 - Elsevier
Glaucoma is a progressive optic neuropathy with primary and secondary forms. Iatrogenic
glaucoma secondary to medications is potentially blinding but preventable. Most drug …
glaucoma secondary to medications is potentially blinding but preventable. Most drug …
[HTML][HTML] Drug-induced acute angle-closure glaucoma: a review
MC Yang, KY Lin - Journal of current glaucoma practice, 2019 - ncbi.nlm.nih.gov
Aim Our goal is to review current literature regarding drug-induced acute angle-closure
glaucoma (AACG) and provide ophthalmologists and general practitioners with a thorough …
glaucoma (AACG) and provide ophthalmologists and general practitioners with a thorough …
Some current ideas on the pathogenesis and the role of neuroprotection in glaucomatous optic neuropathy
The primary features of glaucomatous optic neuropathy are characteristic changes in the
optic nerve head, a decrease in number of surviving ganglion cells and a reduction in vision …
optic nerve head, a decrease in number of surviving ganglion cells and a reduction in vision …
[HTML][HTML] Antiglaucoma pharmacotherapy
CP Tătaru, VL Purcărea - Journal of medicine and life, 2012 - ncbi.nlm.nih.gov
This review presents the pharmacotherapeutic approaches available in the treatment of
glaucomatous optic neuropathy. Although its etiology is multi-factorial, currently, the main …
glaucomatous optic neuropathy. Although its etiology is multi-factorial, currently, the main …
Managing adverse effects of glaucoma medications
K Inoue - Clinical ophthalmology, 2014 - Taylor & Francis
Glaucoma is a chronic, progressive disease in which retinal ganglion cells disappear and
subsequent, gradual reductions in the visual field ensues. Glaucoma eye drops have …
subsequent, gradual reductions in the visual field ensues. Glaucoma eye drops have …
Medical backgrounders: glaucoma.
FA Medeiros, RN Weinreb - Drugs of Today (Barcelona, Spain …, 2002 - europepmc.org
Glaucoma is a leading cause of irreversible blindness in the world. Currently, glaucoma is
diagnosed as a progressive optic neuropathy with characteristic optic disc and nerve fiber …
diagnosed as a progressive optic neuropathy with characteristic optic disc and nerve fiber …
Cardiovascular and respiratory considerations with pharmacotherapy of glaucoma and ocular hypertension
JA Han, WH Frishman, SW Sun, PM Palmiero… - Cardiology in …, 2008 - journals.lww.com
Glaucoma and ocular hypertension are highly prevalent conditions in individuals over the
age of 40 and are commonly seen together in patients with cardiovascular disease. Many of …
age of 40 and are commonly seen together in patients with cardiovascular disease. Many of …